Metraipolis › archive › dc_7a765d39bcfe

Efficacy of Kan Jang ® in Patients with Mild COVID-19: Interim Analysis of a Randomized, Quadruple-Blind, Placebo-Controlled Trial — Europe PMC PMID:36015163

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/36015163
DOI: 10.3390/ph15081013
License (as archived): solo-consultazione
Archived: 2026-10-08T05:16:57.278Z
SHA-256 of the archived text: 3612002634c7c5e40a0c60d8d243c92b1366a1bc0ea3f1f0d60e4a3e2e998c50
Stable URL of this page: https://metraipolis.com/documento/dc_7a765d39bcfe

How to cite

Efficacy of Kan Jang ® in Patients with Mild COVID-19: Interim Analysis of a Randomized, Quadruple-Blind, Placebo-Controlled Trial — Europe PMC PMID:36015163 — Europe PMC (en), https://europepmc.org/article/MED/36015163 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7a765d39bcfe (Metraipolis archive dc_7a765d39bcfe, sha256 3612002634c7c5e40a0c60d8d243c92b1366a1bc0ea3f1f0d60e4a3e2e998c50)

BibTeX

@misc{dc7a765d39bcfe,
  title = {Efficacy of Kan Jang ® in Patients with Mild COVID-19: Interim Analysis of a Randomized, Quadruple-Blind, Placebo-Controlled Trial — Europe PMC PMID:36015163},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/36015163},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7a765d39bcfe; sha256 3612002634c7c5e40a0c60d8d243c92b1366a1bc0ea3f1f0d60e4a3e2e998c50},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/36015163. Agents can read the archived copy with the MCP tool read_document.